Medicine Compliance Aid Stability
TavegilNovartis Pharmaceuticals UK Ltd
Novartis Pharmaceuticals UK Ltd
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Store in airtight containers. Protect from light.
25 October 2022
Lactation Safety Information
Cetirizine/Loratadine. If a sedating antihistamine required chlorphenamine is preferred (see summary
No published evidence of safety
Case report of sedation in a breastfed infant
Monitor infant for drowsiness
3 August 2020